目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Route of Administration
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Antibacterial Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Antibacterial Drugs Market 2018 - 2022 ($ million)
4.2 Route of Administration segment analysis 2018 - 2022
Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.3 Drug Class segment analysis 2018 - 2022
Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Route of Administration
6.1 Market segments
Chart on Route of Administration - Market share 2023-2028 (%)
Data Table on Route of Administration - Market share 2023-2028 (%)
6.2 Comparison by Route of Administration
Chart on Comparison by Route of Administration
Data Table on Comparison by Route of Administration
6.3 Intravenous - Market size and forecast 2023-2028
Chart on Intravenous - Market size and forecast 2023-2028 ($ million)
Data Table on Intravenous - Market size and forecast 2023-2028 ($ million)
Chart on Intravenous - Year-over-year growth 2023-2028 (%)
Data Table on Intravenous - Year-over-year growth 2023-2028 (%)
6.4 Oral - Market size and forecast 2023-2028
Chart on Oral - Market size and forecast 2023-2028 ($ million)
Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Chart on Oral - Year-over-year growth 2023-2028 (%)
Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Route of Administration
Market opportunity by Route of Administration ($ million)
Data Table on Market opportunity by Route of Administration ($ million)

7 Market Segmentation by Drug Class
7.1 Market segments
Chart on Drug Class - Market share 2023-2028 (%)
Data Table on Drug Class - Market share 2023-2028 (%)
7.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
7.3 B-lactam - Market size and forecast 2023-2028
Chart on B-lactam - Market size and forecast 2023-2028 ($ million)
Data Table on B-lactam - Market size and forecast 2023-2028 ($ million)
Chart on B-lactam - Year-over-year growth 2023-2028 (%)
Data Table on B-lactam - Year-over-year growth 2023-2028 (%)
7.4 Quinolones - Market size and forecast 2023-2028
Chart on Quinolones - Market size and forecast 2023-2028 ($ million)
Data Table on Quinolones - Market size and forecast 2023-2028 ($ million)
Chart on Quinolones - Year-over-year growth 2023-2028 (%)
Data Table on Quinolones - Year-over-year growth 2023-2028 (%)
7.5 Macrolids - Market size and forecast 2023-2028
Chart on Macrolids - Market size and forecast 2023-2028 ($ million)
Data Table on Macrolids - Market size and forecast 2023-2028 ($ million)
Chart on Macrolids - Year-over-year growth 2023-2028 (%)
Data Table on Macrolids - Year-over-year growth 2023-2028 (%)
7.6 Tetracyclins - Market size and forecast 2023-2028
Chart on Tetracyclins - Market size and forecast 2023-2028 ($ million)
Data Table on Tetracyclins - Market size and forecast 2023-2028 ($ million)
Chart on Tetracyclins - Year-over-year growth 2023-2028 (%)
Data Table on Tetracyclins - Year-over-year growth 2023-2028 (%)
7.7 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Drug Class
Market opportunity by Drug Class ($ million)
Data Table on Market opportunity by Drug Class ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.4 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.5 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.4 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.5 Cipla Inc.
Cipla Inc. - Overview
Cipla Inc. - Business segments
Cipla Inc. - Key news
Cipla Inc. - Key offerings
Cipla Inc. - Segment focus
12.6 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.7 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.8 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.9 Kyorin Pharmaceutical Co. Ltd.
Kyorin Pharmaceutical Co. Ltd. - Overview
Kyorin Pharmaceutical Co. Ltd. - Product / Service
Kyorin Pharmaceutical Co. Ltd. - Key news
Kyorin Pharmaceutical Co. Ltd. - Key offerings
12.10 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Product / Service
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
12.11 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
12.12 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.13 Paratek Pharmaceuticals Inc.
Paratek Pharmaceuticals Inc. - Overview
Paratek Pharmaceuticals Inc. - Product / Service
Paratek Pharmaceuticals Inc. - Key offerings
12.14 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.15 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12.16 STADA Arzneimittel AG
STADA Arzneimittel AG - Overview
STADA Arzneimittel AG - Business segments
STADA Arzneimittel AG - Key offerings
STADA Arzneimittel AG - Segment focus
12.17 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Antibacterial Drugs Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits33: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Route of Administration
Exhibits35: Data Table on Comparison by Route of Administration
Exhibits36: Chart on Intravenous - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Intravenous - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Intravenous - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Intravenous - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits48: Market opportunity by Route of Administration ($ million)
Exhibits49: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits50: Chart on Drug Class - Market share 2023-2028 (%)
Exhibits51: Data Table on Drug Class - Market share 2023-2028 (%)
Exhibits52: Chart on Comparison by Drug Class
Exhibits53: Data Table on Comparison by Drug Class
Exhibits54: Chart on B-lactam - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on B-lactam - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on B-lactam - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on B-lactam - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Quinolones - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Quinolones - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Quinolones - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Quinolones - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on Macrolids - Market size and forecast 2023-2028 ($ million)
Exhibits63: Data Table on Macrolids - Market size and forecast 2023-2028 ($ million)
Exhibits64: Chart on Macrolids - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Macrolids - Year-over-year growth 2023-2028 (%)
Exhibits66: Chart on Tetracyclins - Market size and forecast 2023-2028 ($ million)
Exhibits67: Data Table on Tetracyclins - Market size and forecast 2023-2028 ($ million)
Exhibits68: Chart on Tetracyclins - Year-over-year growth 2023-2028 (%)
Exhibits69: Data Table on Tetracyclins - Year-over-year growth 2023-2028 (%)
Exhibits70: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits71: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits72: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits73: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits74: Market opportunity by Drug Class ($ million)
Exhibits75: Data Table on Market opportunity by Drug Class ($ million)
Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits77: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits78: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits79: Chart on Geographic comparison
Exhibits80: Data Table on Geographic comparison
Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits106: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits107: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits109: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits110: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits111: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits112: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits113: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits114: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits115: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits116: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits117: Market opportunity By Geographical Landscape ($ million)
Exhibits118: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits119: Impact of drivers and challenges in 2023 and 2028
Exhibits120: Overview on criticality of inputs and factors of differentiation
Exhibits121: Overview on factors of disruption
Exhibits122: Impact of key risks on business
Exhibits123: Companies covered
Exhibits124: Matrix on companies position and classification
Exhibits125: Bayer AG - Overview
Exhibits126: Bayer AG - Business segments
Exhibits127: Bayer AG - Key news
Exhibits128: Bayer AG - Key offerings
Exhibits129: Bayer AG - Segment focus
Exhibits130: Bristol Myers Squibb Co. - Overview
Exhibits131: Bristol Myers Squibb Co. - Product / Service
Exhibits132: Bristol Myers Squibb Co. - Key news
Exhibits133: Bristol Myers Squibb Co. - Key offerings
Exhibits134: Cipla Inc. - Overview
Exhibits135: Cipla Inc. - Business segments
Exhibits136: Cipla Inc. - Key news
Exhibits137: Cipla Inc. - Key offerings
Exhibits138: Cipla Inc. - Segment focus
Exhibits139: Eli Lilly and Co. - Overview
Exhibits140: Eli Lilly and Co. - Product / Service
Exhibits141: Eli Lilly and Co. - Key news
Exhibits142: Eli Lilly and Co. - Key offerings
Exhibits143: F. Hoffmann La Roche Ltd. - Overview
Exhibits144: F. Hoffmann La Roche Ltd. - Business segments
Exhibits145: F. Hoffmann La Roche Ltd. - Key news
Exhibits146: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits147: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits148: GlaxoSmithKline Plc - Overview
Exhibits149: GlaxoSmithKline Plc - Business segments
Exhibits150: GlaxoSmithKline Plc - Key news
Exhibits151: GlaxoSmithKline Plc - Key offerings
Exhibits152: GlaxoSmithKline Plc - Segment focus
Exhibits153: Kyorin Pharmaceutical Co. Ltd. - Overview
Exhibits154: Kyorin Pharmaceutical Co. Ltd. - Product / Service
Exhibits155: Kyorin Pharmaceutical Co. Ltd. - Key news
Exhibits156: Kyorin Pharmaceutical Co. Ltd. - Key offerings
Exhibits157: Lupin Ltd. - Overview
Exhibits158: Lupin Ltd. - Product / Service
Exhibits159: Lupin Ltd. - Key news
Exhibits160: Lupin Ltd. - Key offerings
Exhibits161: Merck KGaA - Overview
Exhibits162: Merck KGaA - Business segments
Exhibits163: Merck KGaA - Key news
Exhibits164: Merck KGaA - Key offerings
Exhibits165: Merck KGaA - Segment focus
Exhibits166: Novartis AG - Overview
Exhibits167: Novartis AG - Business segments
Exhibits168: Novartis AG - Key news
Exhibits169: Novartis AG - Key offerings
Exhibits170: Novartis AG - Segment focus
Exhibits171: Paratek Pharmaceuticals Inc. - Overview
Exhibits172: Paratek Pharmaceuticals Inc. - Product / Service
Exhibits173: Paratek Pharmaceuticals Inc. - Key offerings
Exhibits174: Pfizer Inc. - Overview
Exhibits175: Pfizer Inc. - Product / Service
Exhibits176: Pfizer Inc. - Key news
Exhibits177: Pfizer Inc. - Key offerings
Exhibits178: Sanofi SA - Overview
Exhibits179: Sanofi SA - Business segments
Exhibits180: Sanofi SA - Key news
Exhibits181: Sanofi SA - Key offerings
Exhibits182: Sanofi SA - Segment focus
Exhibits183: STADA Arzneimittel AG - Overview
Exhibits184: STADA Arzneimittel AG - Business segments
Exhibits185: STADA Arzneimittel AG - Key offerings
Exhibits186: STADA Arzneimittel AG - Segment focus
Exhibits187: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits188: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits189: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits190: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits191: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits192: Inclusions checklist
Exhibits193: Exclusions checklist
Exhibits194: Currency conversion rates for US$
Exhibits195: Research methodology
Exhibits196: Information sources
Exhibits197: Data validation
Exhibits198: Validation techniques employed for market sizing
Exhibits199: Data synthesis
Exhibits200: 360 degree market analysis
Exhibits201: List of abbreviations